 You may continue taking the study drugs in Part 1 for up to 12 cycles. You may continue taking the study drugs in Part 2 for up to 8 cycles. You will no longer be able to take the drugs if the disease gets worse, if intolerable side effects occur, or if you are unable to follow study directions. 